Who owns SAB BIOTHERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sab Biotherapeutics stock

Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Marshall Wace 4.6M $3.2M 100% Dec 2023
 View chart
RA Capital Management 2.4M $1.6M 100% Dec 2023
 View chart
Commodore Capital 1.8M $13M 100% Dec 2023
 View chart
Institutional & Family Asset Management 19k $87k 100% Mar 2024
 View chart
Spectrum Wealth Counsel 503.00 $2.3k 100% Mar 2024
 View chart
Princeton Global Asset Management 500.00 $2.3k 100% Mar 2024
 View chart
Gs Investments 200.00 $908.000000 100% Mar 2024
 View chart